```html

Xanthopsia (Yellow‑Tinted Vision)

What is Xanthopsia?

Xanthopsia, derived from the Greek words xanthos (yellow) and opsis (vision), is a visual disturbance in which the affected individual perceives objects with a yellow tint. The phenomenon can be partial (affecting only part of the visual field) or total, and it may be transient (lasting seconds to minutes) or chronic (persisting for weeks or longer). Xanthopsia is not a disease itself; rather, it is a symptom that signals an underlying problem with the eye, the optic pathways, or the brain’s visual processing centers.

Because color perception is a complex process that involves photoreceptor cells (cones), retinal processing, and cortical interpretation, disruptions at any of these levels can produce a yellow hue. The condition can be unsettling and may impair daily activities such as reading, driving, and operating machinery.

Key points:

• Yellow‑tinged vision is called xanthopsia.
• It can be temporary or persistent.
• Often indicates an underlying medical, ocular, or pharmacologic issue.

Common Causes

Below are the most frequently reported conditions and factors that can lead to xanthopsia. In many cases, more than one factor may be involved.

• Medication side‑effects – especially digoxin, phosphodiesterase‑5 inhibitors (e.g., sildenafil), and certain antimalarials.
• Jaundice – high bilirubin levels in the bloodstream can cause yellow discoloration of the sclera and affect visual perception.
• Cataracts – particularly nuclear sclerosis, which scatters short‑wavelength light and leaves a yellow‑dominant image.
• Retinal diseases – such as retinitis pigmentosa or macular degeneration that alter cone function.
• Optic neuritis – inflammation of the optic nerve often linked to multiple sclerosis.
• Brain lesions – strokes, tumors, or traumatic injuries affecting the occipital lobe or visual pathways.
• Vitamin A toxicity – excess retinoids can modify photoreceptor response.
• Age‑related changes – normal aging leads to yellowing of the lens, which can be perceived as xanthopsia before a cataract becomes clinically evident.
• Exposure to certain chemicals – such as quinine or phenothiazines, which can interfere with retinal metabolism.
• Systemic diseases – severe liver disease, diabetes mellitus with retinal involvement, or hyperbilirubinemia in newborns (physiologic jaundice).

Associated Symptoms

Patients who notice yellow‑tinged vision often report additional visual or systemic clues that help clinicians narrow the cause:

• Glare or halos around lights.
• Reduced visual acuity or blurry vision.
• Photophobia (sensitivity to light).
• Floaters, flashes, or a “curtain” effect suggesting retinal detachment.
• Headache, especially with eye movement.
• Neurological signs: weakness, facial droop, or difficulty speaking (possible stroke).
• Systemic signs of liver disease: dark urine, pale stools, abdominal pain.
• Palpitations or irregular heartbeat (possible digoxin toxicity).
• Feeling of “fog” or difficulty distinguishing colors other than yellow.

When to See a Doctor

Not every episode of yellow‑tinged vision requires emergency care, but prompt evaluation is essential when any of the following occurs:

• Sudden onset of xanthopsia, especially if it lasts longer than a few minutes.
• Vision loss in one or both eyes, even if partial.
• Accompanying neurological symptoms (weakness, numbness, slurred speech).
• Chest pain, palpitations, or shortness of breath (possible cardiac drug toxicity).
• Signs of severe jaundice: deep yellow skin, itching, abdominal swelling.
• Persistent headache or visual distortion after a head injury.
• New symptoms while taking a medication known to affect vision.

In such situations, contact your primary care physician, eye specialist (ophthalmologist), or go to an emergency department.

Diagnosis

Clinicians use a step‑wise approach to identify the root cause of xanthopsia.

1. Detailed History

• Medication review – prescription, over‑the‑counter, herbal supplements.
• Recent illnesses, surgeries, or head trauma.
• Systemic disease history (liver, heart, diabetes, autoimmune).
• Onset, duration, and pattern of the visual change.

2. Physical Examination

• Comprehensive eye exam: visual acuity, pupillary reactions, slit‑lamp evaluation of the cornea, lens, and anterior chamber.
• Fundoscopic (dilated) exam to assess the retina, optic disc, and macula.
• General exam for jaundice, skin changes, neurologic deficits.

3. Laboratory Tests

• Serum bilirubin, liver function panel (AST, ALT, ALP, GGT).
• Digoxin serum level if the patient is on the drug.
• Vitamin A and vitamin B12 levels (deficiency/toxicity).
• Blood glucose and HbA1c for diabetic retinopathy screening.

4. Imaging Studies

• Optical Coherence Tomography (OCT) – high‑resolution cross‑section of retinal layers.
• Fluorescein angiography – evaluates retinal blood flow.
• CT or MRI of the brain – indicated when a central cause (stroke, tumor) is suspected.

5. Specialized Tests

• Electroretinography (ERG) – measures retinal response to light, useful in inherited retinal disorders.
• Visual field testing – defines the extent of visual field loss.

Treatment Options

Treatment is directed at the underlying cause; the yellow hue usually resolves once the primary issue is corrected.

Medication‑Related Xanthopsia

• Adjust dose or discontinue the offending drug (e.g., lower digoxin dose under cardiac supervision).
• Switch to alternative therapy when possible.

Liver‑Related Causes

• Treat underlying liver disease – antiviral therapy for hepatitis, lifestyle changes for fatty liver, or surgical intervention for biliary obstruction.
• Phototherapy for severe neonatal jaundice.

Cataract‑Induced Yellow Vision

• Early cataract surgery (phacoemulsification) restores clear vision and eliminates the color shift.
• Use of anti‑oxidant rich diet (vitamins C, E, lutein) may slow progression, but surgery remains definitive.

Retinal or Optic Nerve Disorders

• Corticosteroids or immunosuppressive agents for optic neuritis.
• Anti‑VEGF injections for neovascular age‑related macular degeneration.
• Management of diabetic retinopathy with laser photocoagulation or vitrectomy.

General Supportive Measures

• Protect eyes from glare using polarized sunglasses.
• Maintain good hydration and a balanced diet rich in omega‑3 fatty acids, lutein, and zeaxanthin.
• Regular eye examinations—at least once every 1–2 years for adults, more often if you have risk factors.

Prevention Tips

While not all causes are preventable, many strategies reduce the risk of developing xanthopsia:

• Medication vigilance – keep an up‑to‑date list of drugs; ask your doctor about visual side‑effects.
• Liver health – limit alcohol, maintain a healthy weight, vaccinate against hepatitis A and B.
• Eye protection – wear UV‑blocking sunglasses, avoid looking directly at bright lights.
• Control systemic diseases – strict blood‑sugar control for diabetes, blood‑pressure management for hypertension.
• Regular eye check‑ups – detect early cataract changes or retinal disease before symptoms appear.
• Dietary eye support – foods high in lutein (spinach, kale) and zeaxanthin (corn, eggs) may help maintain normal color perception.
• Safe medication use – never share prescription drugs; use the lowest effective dose.

Emergency Warning Signs

Key Take‑aways

Xanthopsia is a yellow‑tinted visual disturbance that can stem from medication side‑effects, liver disease, cataracts, retinal or optic nerve pathology, and several systemic conditions. Prompt evaluation—starting with a thorough history and eye exam—helps identify the cause and guide treatment. While many cases resolve after addressing the underlying issue, some require urgent care, especially when accompanied by neurological or cardiac symptoms. Maintaining liver health, managing systemic diseases, and regular ophthalmic follow‑up are the cornerstones of prevention.

References (selected):

• Mayo Clinic. “Digoxin toxicity.” Accessed May 2026.
• American Academy of Ophthalmology. “Cataract surgery basics.” 2025.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Jaundice in adults.” 2024.
• World Health Organization. “Guidelines for the management of liver disease.” 2023.
• Cleveland Clinic. “Optic neuritis: symptoms and treatment.” 2025.

```